The U.S. biathlon team hopes to end its Olympic medal drought with the help of Campbell Wright, a rising star and dual ...
Couples are often under the influence of biological hormones triggered by falling in love. We are blinded by the feeling of ...
During the Wednesday, Jan. 14 episode of the 'Chrisley Confessions 2.0' podcast, Todd and Julie Chrisley gave an update on ...
South Korean pharmaceutical giant Samsung Biologics is making a major acquisition in the D.C. suburbs to establish its first U.S. manufacturing facility. The company reached an agreement to acquire ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal would give the South ...
A South Korean biomanufacturing giant is set to purchase its first drug production facility in the U.S. for a sum worthy of its tech giant parent. Samsung Biologics is the world’s largest contract ...
Samsung Biologics has agreed to buy GSK's Human Genome Sciences for $280 million, expanding the company's footprint into the U.S. market. Samsung Biologics, a biopharmaceutical contract development ...
SEOUL, Dec 22 (Reuters) - South Korea's Samsung Biologics (207940.KS), opens new tab said on Monday it is acquiring its first U.S. drug production facility from GSK (GSK.L), opens new tab for $280 ...
Right now, the debate about consciousness often feels frozen between two entrenched positions. On one side sits computational functionalism, which treats cognition as something you can fully explain ...
The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced. The ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. Biological age tests are one of the most talked-about tools in ...
A new guidance document issued by the FDA this week offers recommendations for how makers of prescription biosimilars and biologic reference products should approach promotional advertising and ...